The Impact of Artificial Intelligence on Personalized Medicine
DOI:
https://doi.org/10.17140/vroj-7-119Keywords:
Artificial intelligence (AI), Personalized medicine, Diagnosis, Cancer, Genetic defectsAbstract
Artificial intelligence (AI) has the potential to revolutionize personalized medicine by enabling more accurate and efficient
diagnoses, treatment selection, and disease prediction, for instance, cancer, diabetes, and many genetic defects. AI algorithms
can analyze large amounts of patient data, including genomic data, medical history, and lifestyle factors, to identify patterns and
predict disease risk, treatment effectiveness, and potential adverse reactions. AI can also support the development of personalized
treatment plans based on the unique characteristics of each patient, such as their genetic makeup, disease stage, and health history.
This approach, known as precision medicine, can significantly improve patient outcomes and reduce healthcare costs by focusing
on the most effective treatments for each individual. Moreover, AI-powered tools can help clinicians identify patients at high risk
of developing a particular disease and intervene early to prevent or delay its onset. This can be particularly crucial for chronic
diseases like diabetes and heart disease, which can be managed more effectively with early intervention. Furthermore, AI can
significantly improve research efficiency and outcomes in personalized medicine by enhancing patient stratification during clinical
trials. By leveraging AI-driven algorithms, researchers can identify and group patients based on various factors, such as genetic
profiles, disease characteristics, and treatment responsiveness. It should be noted that the impact of AI on personalized medicine
is still being explored, and there are many opportunities for this technology to transform healthcare in the coming years. However,
it is crucial to ensure that AI is used ethically and responsibly to respect patient privacy and guarantee the accuracy and reliability
of the data being analyzed. This review article explores the various ways AI can impact personalized medicine.
References
He J, Baxter SL, Xu J, Xu J, Zhou X, Zhang K.The practical implementation of artificial intelligence technologies in medicine. Nat Med. 2019; 25: 30-36. doi: 10.1038/s41591-018-0307-0
Dong Z, Chau MHK, Zhang Y, et al. Detection of absence of heterozygosity using low-pass genome sequencing: Validation in clinical cytogenetics. Genet Med. 2021; 23: 1225-1233. doi: 10.1038/ s41436-021-01128-7
Fitzgerald J, Higgins D, Mazo Vargas C, et al. Future of bio-marker evaluation in the realm of artificial intelligence algorithms: Application in improved therapeutic stratification of patients with breast and prostate cancer. J Clin Pathol. 2021; 74: 429-4324. doi: 10.1136/jclinpath-2020-207351
Pei Q, Luo Y, Chen Y, Li J, Xie D, Ye T. Artificial intelligence in clinical applications for lung cancer: Diagnosis, treatment and prognosis. Clin. Chem. Lab. Med. 2022; 60: 1974-1983. doi: 10.1515/cclm-2022-0291
Yang X, Wu J, Chen X. Application of artificial intelligence to the diagnosis and therapy of nasopharyngeal cancer. J. Clin. Med. 2023; 12: 3077-3082. doi: 10.3390/jcm12093077
Din NMU, Dar RA, Rasool M, Assad A. Breast cancer de-tection using deep learning: Datasets, methods, and challenges ahead. Comput Biol Med. 2022; 149: 106073. doi: 10.1016/j.comp-biomed.2022.106073
Shatte ABR, Hutchinson DM, Teague SJ. Machin learning in mental health: A scoping review of method and applications. Psy-col. Med. 2019; 49: 1426-1448. doi: 10.1017/S0033291719000151
Pillay TS. Artificial intelligence in pathology and laboratory medicine. J. Clin. Pathol. 2021; 74: 407-408. doi: 10.1136/jclin-path-2021-207682
Dilsizian ME, Siegel EL. Machine meets biology: A Primer on artificial intelligence in cardiology and cardiac imaging. Curr. Car-diol. Rep. 2018; 20: 139-146. doi: 10.1007/s11886-018-1074-8
Prabhakar B, Singh RK, Yadav KS. Artificial intelligence (AI) 10 Khansari N impacting diagnosis of glaucoma and understanding the regula-tory aspects of AI-based software as medical device. Comput. Med. Imaging. Graph. 2021; 87: 101818. doi: 10.1016/j.compmed-imag.2020.101818
Waden J. Artificial intelligence and its role in the development of personalized medicine and drug control. Waist J. Comp. Math. Sci. 2022; 85: 126-133.
Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK. Artificial intelligence in drug discovery and development. Drug Dis-cov Today. 2021; 26: 80-93. doi: 10.1016/j.drudis.2020.10.010
Wilmink G, Dupey K, Alkire S, et al. Artificial intelligence-powered digital health Platform and wearable devices improve outcomes for older adults in assisted Living communities: Pilot in-tervention Study. JMIR Aging. 2020; 3: e19554. doi: 10.2196/19554
Strunga M, Urban R, Surovková J, Thurzo A. Artificial intel-ligence systems assisting in the assessment of the course and reten-tion of orthodontic treatment. Healthcare (Basel). 2023; 11: 683-689. doi: 10.3390/healthcare11050683
Johnson Bk, Wei WQ, Weeraratne D, et al. Personalized medi-cine, AI, and the future of personalized health care. Clin. Trans. Sci. 2021; 14: 86-93. doi: 10.1111/cts.12884
Mukhopadhyay A, Summer J, Ling LH, et al. Personalized dos-ing: AI algorithm protocol for feasibility study in patients with hy-pertension and type II diabetes mellitus. Int. J. Environ. Res. Pub. Health. 2022; 19: 8979-8989. doi: 10.3390/ijerph19158979
Barrett M, Boyne J, Brandts J, et al. Artificial intelligence sup-ported patient self-care chronic heart failure: A paradigm shift from reactive to predictive, preventive, personalized care. EPMA J. 2019; 10: 445-464. doi: 10.1007/s13167-019-00188-9
Yu YD, Lee KS, Man Kim J, et al. Artificial intelligence for predicting survival following deceased donor liver transplantation: Retrospective multicenter study. Int. J. Surg. 2022; 105: 106838- 106845. doi: 10.1016/j.ijsu.2022.106838
Huang R-H, Hong Y-K, Du H, Ke W-Q, Lin B-B, Li Y-L. A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerabil-ity in primary prostate cancer. J. Trad. Med. 2023; 21: 20-38. doi: 10.1186/s12967-023-03872-7
Lin B, Wu S. Digital transformation in personalized medicine with artificial intelligence and internet medical things. J. Integ. Biol. 2022; 26: 77-81. doi: 10.1089/omi.2021.0037
Sau A, Mishra J, Kushwaha N. Artificial intelligence (AI) in drug and pharmaceuticals. Comb. Chem. High Throughput Screen. 2022; 25: 1818-1837. doi: 10.2174/1386207325666211207153943
Capece G, Lorenzi F. Blockchain and healthcare: Opportunities and prospects for the EHR. Sustainability. 2020; 12: 9693-9698. doi: 10.3390/su12229693
Penikalapati P, Rao A. Health analytics by engaging machine learning. Sci. Info. Tech. Letters. 2020. 1: 24-34. doi: 10.31763/sitech. v1i1.32
Wei L, Xiaoguang Y, Jianguan W, et al. Improving kidney out-comes in patients with nondiabetic chronic kidney disease through an artificial intelligence-based health coaching mobile app: Retro-spective cohort study. JMIR Mhealth Uhealth. 2023; 11: e45531. doi: 10.2196/45531
Sneller J, Buchanan H, Pareh S. The impact of amelogenesis imperfecta and support needs of adolescents with AI and their parents: An exploratory study. Int. J. Pediatric. Dent. 2014; 24: 409- 416. doi: 10.1111/ipd.12086
Piccialli F, Giampaolo F, Prezioso E, Camacho D. Artificial intelligence and health care: Forecasting of medical bookings through multi-source time-series fusion. Info. Fusion. 2021; 74: 1-16. doi: 10.1016/j.inffus.2021.03.004
Ilan Y. Improving global healthcare and reducing costs using second-generation artificial intelligence-based pills: A market dis-ruptor. Int. J. Environ. Res. Public. 2021; 18: 811-821. doi: 10.3390/ ijerph18020811
Ho D, Wang P, Kee T. Artificial intelligence in nanomedicine. Nanoscale Horizon. 2019; 4: 365-377. doi: 10.1039/C8NH00233A
Randhawa GK, Jackson M. The role of artificial intel-ligence in learning and professional development for health-care professionals. Health Manage. Forum. 2020; 33: 19-24. doi: 10.1177/0840470419869032
Kundu G, Shetty N, Shetty R, et al. Artificial intelligence-based stratification of demographic ocular surface high-risk factors in progression of keratoconus. Indian J. Ophthalmology. 2023; 71: 1882- 18888. doi: 10.4103/IJO.IJO_2651_22
Mamalakis M, Dwivedi K, Sharkey M, Alabed S, Kiely D. A transparent artificial intelligence framework to assess lung disease in pulmonary hypertension. Nat. Scientific Reports. 2023; 13: 3812- 3829. doi: 10.1038/s41598-023-30503-4
Paranjape K, Schinkel M, Panday RN, Car J, Nanayakka P. In-troducing artificial intelligence training in medical education. JMIR Med Educ. 2019; 5: e16048-e16055. doi: 10.2196/16048
Bat M, Rabindranath M, Chara BS, Simonetto DA. Artifi-cial intelligence, machine learning, and deep learning in liver transplantation. J. Hepatol. 2023; 78: 1216-1233. doi: 10.1016/j. jhep.2023.01.006
Shillan D, Sterne JA, Chempneys A, Gibbson B. Use of ma-chine learning to analyze routinely collected intensive care unit Review | Volume 7 | Number 1 | Khansari N data: A systemic review. Critical Care. 2019; 23: 284-295. doi: 10.1186/s13054-019-2564-9
Coravos A, Goldsack JC, Karlin DR, et al. Digital medicine: A primer on measurement. Digit Biomark. 2019; 3: 31-71. doi: 10.1159/000500413
Kataria S, Ravindran V. Digital health: A new dimension in rheumatology patient care. Rheumatol. Int. 2018; 38: 1949-1957. doi: 10.1007/s00296-018-4037-x
Ellis TD, Earhart GM. Digital therapeutics in Parkinson’s dis-ease: practical applications and future potential. J. Parkinson’s Dis. 2021; 11: S95-S101. doi: 10.3233/JPD-202407
Keraside A. Artificial intelligence and the ongoing need for empathy, compassion, and trust in health care. Bull. World Health Organ. 2020; 98: 245-250. doi: 10.2471/BLT.19.237198
Frank PP, Lu MX, Sasse EC. Educational and emotional needs of patients with myelodysplastic syndromes: Analysis of multi-country social media. Adv. Therap. 2023; 40: 159-173. doi: 10.1007/ s12325-022-02277-0
Zang J, Zhang XZ. Ethics and governance of trustworthy medical artificial intelligence. BMC Med Inform Decis Mak. 2023; 23: 7-22. doi: 10.1186/s12911-023-02103-9
Alajaji SA, Khoury ZH, Elgharib M, et al. Generative adver-sarial networks in digital histopathology: Current applications, limi-tations, ethical considerations, and future directions. Med. Pathol. 2023; 37: 100369-100378. doi: 10.1016/j.modpat.2023.100369
Ahmed L, Constantinidou A, Chatzittofis A. Patients’ perspec-tives related to ethical issues and risks in precision medicine: A systematic review. Front Med (Lausanne). 2023; 10: 3389-3394. doi: 10.3389/fmed.2023.1215663
Baker N, Kevalik T, Lorenzini I, Spangler S, et al. Artificial in-telligence in neurogenerative disease research: Use of IBM Watson to identify additional RNA-binding proteins altered amyotrophic lateral sclerosis. Act Neuropath. 2018. 135:227-247. doi: 10.1007/ s00401-017-1785-8
Jia W, Fisher EB. Application and prospect of artificial intel-ligence in diabetes care. Med. Rev. 2023; 3: 102-104. doi: 10.1515/ mr-2022-0039
Lorfino F, Cross S, Davenport TA, et al. A digital platform de-signed for youth mental health services to deliver personalized and measurement-based care. Front. Psychiatry. 2019; 10: 595-605. doi: 10.3389/fpsyt.2019.00595
Yadav SK, Singh MK, Pal S. Artificial intelligence model for Parkinson’s disease detection using machine learning algorithms. Biomed. Materials & Devices. 2023; 1: 899-911. doi: 10.1007/s44174- 023-00068-x
Escohar-Grisales D, Rios-Urrego CD, Orozco-Arroye JR. Deep learning and artificial intelligence applied to model speech Submit your article to this journal | https://openventio.org/online-manuscript-submission-system/ 12 Khansari N and language in Parkinson’s disease. Diagnosis. 2023; 13: 2163-2179. doi: 10.3390/diagnostics13132163
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Vaccination Research (VR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.